Attention Therapeutics publishes results of a randomized controlled study in the Journal of Attention Disorders (JAD) demonstrating improvements in attention and academic performance.

Groundbreaking study in Journal of Attention Disorders demonstrates promise of new product as treatment for ADHD Waltham, MA February 16, 2016 – Attention Therapeutics LLC, a wholly owned subsidiary of Atentiv LLC and developer of digital health products, announced the results of a randomized, controlled and parallel human phase II clinical trial, which demonstrated that […]